Posted on 6月 1, 20226/1/22
KAM Reimagined: Building a Strategic Framework to Empower Key Account Management
Posted on 5月 24, 20225/24/22
Overcome In-Licensing Barriers to Increase Throughput of Assets
Posted on 5月 13, 20225/13/22
Is Your Digital Communication Strategy Up to Par?
Posted on 4月 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on 4月 8, 20224/8/22
EVERSANA Featured in NIH Study Detailing the Cost of Treating Rare Disease
Posted on 4月 6, 20224/6/22
Reframing the Challenges of Access and ROI
Posted on 3月 23, 20223/23/22
How Do We Pay for a Cure? How to Put a Price on Life-changing Treatments
Posted on 3月 22, 20223/22/22
Podcast: Achieving Cell and Gene Therapy Commercial Excellence
Posted on 2月 24, 20222/24/22
THINK BEYOND THE THERAPY: Demystifying the Complexities of Cell and Gene Therapy Commercialization
Posted on 1月 14, 20221/14/22